Prelude Therapeutics PRLD shares fell 17.4% to $0.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $49.5 million. Stoke Therapeutics STOK shares declined by 11 ...
Coherent reported quarterly earnings of 95 cents per share which beat the analyst consensus estimate of 69 cents per share. The company reported quarterly sales of $1.44 billion which beat the analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results